

| Número de catálogo | HW412026 |
|---|---|
| Reactividad de especies | Human |
| Aplicaciones | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Especie huésped | Human |
| Clonalidad | Monoclonal |
| Isotipo | IgG |
| ID de clon | HGS101 |
| Actividad biológica | HGS101 (1 h) shows EC 50 values of 0.001 ug/mL for Maraviroc ()-sensitive, 0.0003 ug/mL for Maraviroc -resistant, and 0.00002 ug/mL for Maraviroc -resistant HIV-1 in the presence of Maraviroc in JC6 cells [1]. HGS101 (1 h) shows EC 50 values of 0.03 ug/mL for Maraviroc -sensitive, 0.03 ug/mL for Maraviroc -resresistant, and 0.01 ug/mL for Maraviroc -resistant HIV-1 in the presence of Maraviroc in PBMCs [1]. HGS101 (0.3 ug/ mL, 1 h) restores Maraviroc inhibition (EC 50 of 0.007 nM) of Maraviroc -resistant HIV-1 in PBMCs [1]. HGS101 (10 mg/kg, i.v., every 15 days for 10 times) shows anti-HIV activity by inhibiting CCR5 signaling in simian immunodeficiency virus-uninfected RMs models [2]. . Reduced the levels of CCR5 + T-cells in blood and lymph nodes. Induced a complex anatomic redistribution of CD25 + T-cell. Induced specific changes in the transcriptional profile of leukocytes. |
| Sistema de expresión | Mammalian cells |
| Objetivo | C-C CKR-5, CC-CKR-5, CMKBR5, HIV-1 fusion coreceptor, CHEMR13, CCR5, C-C chemokine receptor type 5, CD195, CCR-5 |
| Nivel de endotoxinas | < 10 EU/mg |
| Pureza | >95% purity as determined by SDS-PAGE. |
| Purificación | Protein A/G purified from cell culture supernatant. |
| Número de acceso | P51681 |
| Forma | Liquid |
| Buffer de almacenamiento | 0.01M PBS pH 7.4 Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote. |
| Estabilidad y almacenamiento | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Nombres alternativos | HGS101 |
| Fondo | C-C chemokine receptor type 5 (CD195/CCR5) is a ~40 kDa protein. Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation. Participates in T-lymphocyte migration to the infection site by acting as a chemotactic receptor. 1. Sharapova, TN. et al. (2018) Acta naturae 10, 115-120. PMID: 30713770 |
| Referencias | 1. Latinovic O, et al. CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells. Virology. 2011 Mar 1;411(1):32-40. [HW412026] 2. aaffe JE, et al. CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques. J Med Primatol. 2012 Feb;41(1):24-42. [HW412026] |
| Nota | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for Research Grade Anti-Human CD195/CCR5 (HGS101)




Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.
Correo: [email protected]


+86-027-65523339
Edificio C, No. 666, Calle Shendunsi, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский